Class I MHC-peptide interactions: structural requirements and functional implications.
H M Grey, A Sette, W. Martin Kast(University of Southern California), Antonella Vitiello(University of Naples Federico II), Ralph T. Kubo, J Ruppert(Cytel (United States)), John Sidney(La Jolla Institute for Immunology)
PubMed
January 1, 1995
Cited by 33
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
HLA class I supertypes: a revised and updated classification
|BMC Immunology|2008|801